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Abstract
Prostaglandin (PG) A2 (PGA2) and v12-PGJ2 have potent antiproliferative activity on various tumor cell growths in vitro.
In this study, we investigated the mechanism of PGA2/v12-PGJ2-mediated apoptosis, including intracellular apoptosis-
related genes in human hepatocarcinoma Hep3B cells. Hep3B cells treated with PGA2/v12-PGJ2 showed that a time-
dependent DNA fragmentation characterized by marked apoptosis and the elevation of c-myc mRNA expression. In
proportion to the increased c-myc gene transcription, heat shock protein 70 (hsp70) mRNA was induced from 1 to 24 h after
PGA2/v12-PGJ2 treatment. The transfection of c-myc antisense oligomers in Hep3B cells significantly delayed the induction
of HSP70 expression and blocked formation of DNA fragmentation by PGA2/v12-PGJ2. Moreover, overexpressed HSP70
showed an increased resistance to apoptosis by PGA2/v12-PGJ2 treatment. These results demonstrated that the decreased
survival in response to PGA2/v12-PGJ2 was causally related to the amount of c-myc and the induction of c-myc regulated the
elevation of HSP70 which have been known to correlate with a resistance to apoptosis. ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Apoptosis, a distinct process of cell death, is an
endogenous cell suicide mechanism that is speci¢cally
related with a multitude of factors including growth
factors, membrane receptors and transporters, intra-
cellular mediators of signal transduction and nuclear
proteins that relate apoptosis-associated gene expres-
sion [1^4]. Cyclopentenone prostaglandin (PG) A2
(PGA2) and v12-PGJ2, enzymatic dehydration me-
tabolites of PGE2 and PGD2, respectively, showed
many biological functions such as the regulation of
cell proliferation and di¡erentiation [5]. PGA2, PGE2
and v12-PGJ2 have antiproliferative activity on the
growth of various tumor cells in vitro with character-
istic morphological and biochemical features of
apoptosis [6^11]. These cardinal apoptotic ¢ndings,
such as appearance of DNA fragmentation, apop-
totic bodies and induction of p53/p21 (WAF-1/CIP-
1) in L1210 and SK-HEP-1 cells by PGA2 and v12-
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PGJ2 were inhibited by pretreatment of cyclohexi-
mide (CHX) [12,13]. Although these results increase
a possibility that one or more de novo synthetic pro-
teins induced by PGs may be required for the initia-
tion of apoptosis, the molecular mechanism by which
PGs function on apoptosis of tumor cells remains to
be elucidated.
The proto-oncogene c-myc is usually implicated in
cell di¡erentiation, cell-cycle progression and also
has a central role in some forms of apoptosis
[14,15]. Cytostatic and cytotoxic e¡ects of PGA2/
v12-PGJ2 on the growth of tumor cells were associ-
ated with the reduction of c-myc mRNA [16,17].
Constitutively expressed c-myc expression in an IL-
3-dependent myeloid cell line can suppress cell cycle
arrest and accelerate apoptosis [18]. These opposing
roles of c-myc on the induction of tumor cell apop-
tosis require other gene products that may modulate
di¡erent outcome of c-myc expression on a tumor
cell. It was reported that PGA2/v12-PGJ2 can induce
the production of several proteins, such as heme oxy-
genase [19], gadd153 [20], Q-glutamylcysteine synthe-
tase [21], haptoglobin (HP), and heat shock protein
(HSP) [22,23]. The 69 kDa protein induced in L1210
cells by PGD2 is a HSP70 family and the induction
of this protein was inhibited by pretreatment of
CHX [23]. The involvement of HSP in conjunction
with antiproliferative e¡ects of PGs on the growth of
tumor cells has been suggested [24^26]. These pre-
vious studies indicate that c-Myc and HSP70 may
have correlation in PGA2/v12-PGJ2 induced tumor
cell apoptosis as an important modulators. The
mechanism of apoptosis prevention has not been
clari¢ed, but recently it has been suggest that bcl-2
prevents apoptosis induced by c-myc [27]. In some
systems, it can inhibit apoptosis induced by anti-
cancer drugs, such as 5-£uorodeoxyuridine or taxol
[36], by wild-type p53 [37].
To determine the involvement of speci¢c genes on
PGA2/v12-PGJ2 induced Hep3B cell apoptosis, we
examined the changes of apoptosis-related genes level
such as hsp70, c-myc and bcl-2. We also investigated
the biochemical role of HSP70 on induced human
hepatocarcinoma Hep3B cell apoptosis and a possi-
ble relation between hsp70 and c-myc expression dur-
ing apoptosis. The results demonstrate here that
PGA2/v12-PGJ2 can modulate apoptosis by the in-
duction of c-myc and that HSP70 protects the tumor
cells growth from apoptotic activity through contri-
bution of c-myc in the regulation of HSP70 expres-
sion.
2. Materials and methods
2.1. Reagents
PGA2 was purchased from Sigma (St. Louis, Mo)
and v12-PGJ2 was supplied by Ohno Pharmaceutical
Co. (Osaka, Japan). Anti-c-Myc (human, monoclo-
nal, Ab-1) was purchased from Oncogene Science
(Uniondale, NY). Human hepatocellular carcinoma
(Hep3B) cell line and cDNA clones for human hsp70
were obtained from American Type Culture Collec-
tion (ATTC, Rockville, MD). Plasmid pBK-CMV
(CMV, cytomegalovirus) was supplied from Strata-
gene (La Jolla, CA).
2.2. Cell culture condition and treatments
Hep3B cells were grown in RPMI 1640 medium
containing 10% heat-inactivated fetal bovine serum
(Gibco, Grand Island, NY) and 50 Wg/ml of genta-
micin. Cells were plated at a density of 2U105 cells/
ml on a 6-well culture plate and incubated in a 37‡C,
5% CO2 incubator. Treatments were performed on
subcon£uent exponentially growing cultures.
2.3. Determination of cell viability by Trypan blue
exclusion and MTT assay
Cells (5U104) were subcultured in RPMI 1640
supplemented with 10% fetal bovine serum in a 96-
well plate, and treated with PGA2/v12-PGJ2 for var-
ious time periods. For MTT assay, 5 Wl of MTT
agent (5 mg/ml in RPMI 1640) was added and fur-
ther incubated for 2 h. Equal volumes of 0.05 N HCl
in isopropanol were then added, and cell viabilities
were determined colorimetrically by using an auto-
mated 96-well plate reader (Molecular Device, Sun-
nyvale, CA) and measured absorbance at 590 nm. In
the assay of cell growth inhibition, cells on dishes
were trypsinized and viable cells were counted by a
Trypan blue dye exclusion test. Cell growth inhibi-
tion was described as the percentage of treated cells
against control.
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2.4. Determination of DNA fragmentation
DNA fragmentation was detected by an agarose
gel electrophoresis as previously described [13]. Cells
washed with phosphate bu¡er saline (PBS) and in-
cubated in digestion bu¡er (10 mM Tris-HCl, pH
7.4, 100 mM NaCl, 25 mM EDTA, 0.2 mg protein-
ase K, 1% sarkosyl) at 45‡C for 3 h. After the
addition of 2 Wl RNase A (10 mg/ml), mixture con-
taining DNA was placed on 37‡C water-incubator
for 30 min and extracted with an equal volume phe-
nol/chloroform/isoamyl alcohol (25:24:1). Isolated
DNA was loaded into 1.8% agarose gel. After elec-
trophoresis, the gel was stained with ethidium bro-
mide.
2.5. Northern blot analysis
Total cellular RNA was extracted by acid guani-
dium thiocyanate^phenol^chloroform method. A 10
Wg amount of total RNA was separated by electro-
phoresis through 1.5% agarose/formamide gel fol-
lowed by capillary transfer to nylon membrane.
The blots were then hybridized with c-myc or
hsp70 cDNA probe, as well as with a L-actin control
probe. cDNA probes were generated by polymerase
chain reaction with DIG-11-UTP (Boehringer-Mann-
heim, Mannheim, Germany) using speci¢c primer
provided by Clontech (Palo Alto, CA). Hybridiza-
tion was performed by the standard procedure. Fol-
lowing the hybridization, the ¢lters were washed at
room temperature with 2USSC (sodium chloride,
sodium citrate, pH 7.0), 0.1% SDS for 15 min twice
and then 0.1USSC, 0.1% SDS for 15 min twice. The
blots were washed and incubated by alkaline phos-
phatase-conjugated anti-DIG antibody and then hy-
bridized probes were immunodetected with chemilu-
minescent substrate supplied by Boehringer-
Mannheim.
2.6. Immunoblot analysis
Proteins were solubilized from control and PGs
stimulated cells by lysis in gel-running bu¡er (0.25
M Tris-HCl, pH 6.8, 1% SDS, 20% glycerol, 5% L-
mercaptoethanol, 0.02% Bromophenol blue), size
fractionated on 10 or 15% SDS-polyacrylamide gels
and then transferred to nitrocellulose membrane by
electroblotting. After blocking (3% w/v low-fat dry
milk in PBS), the membrane was incubated (2 h at
room temperature) with antibody (dilution 1:500)
speci¢c for human anti-Bcl-2 or anti-c-Myc. Follow-
ing 3U15 min washes (PBS, 0.2% Tween 20), ¢lters
were incubated with the blocking solution containing
1:1000 dilution of the goat anti-mouse IgG peroxi-
dase conjugate. After 3U15 min wash (PBS, 0.2%
Tween 20) the proteins were detected using ECL-
Western blot detection kit (Amersham, Buckingham-
shire, UK) and photographic plates.
2.7. Evaluation of apoptosis
Double staining Annexin-V-Fluos binding and for
cellular DNA of propidium iodide (PI) was per-
formed as followed. Hep3B cells were incubated in
a concentration of 1U105 cells/ml in culture chamber
slide (Nunc, Intermed, Roskilde, Denmark). Cells
were incubated for 10^15 min at 37‡C in 100 Wl of
Annexin-V-Fluos labeling solution (predilute 20 Wl
Annexin-V-Fluos labeling reagent in 1000 Wl incuba-
tion bu¡er (10 mM HEPES/NaOH, pH 7.4, 140 mM
NaCl2, 5 mM CaCl2) and add 20 Wl of PI (50 Wg/
ml)). The cells were evaluated by £uorescence micro-
scopy (use 488 nm excitation and 515 nm long pass
¢lter for detection).
2.8. Transfection and construction
Hep3B cells were transfected with oligonucleotide,
pBK-CMV vector and 1.6 kb hsp70 cDNA using
Lipofectamine liposomal tranfection reagent (Boeh-
ringer-Mannheim). c-myc antisense oligomer (5P-
AACGTTGAGGGGCAT-3P) and sense oligomer
(5P-ATGCCCTCAACGTT-3P) were synthesized
from sequences complementary to the translation
starting site. Cells were seeded 3U105/ml in RPMI
1640 medium and incubated at 37‡C in a 5% CO2
incubator until the cells are 50^80% con£uent. For
each transfection, the two solutions (solution A, di-
lute 2 Wg of DNA into 100 Wl serum free medium;
solution B, dilute 20 Wl of Lipofectamine reagent into
100 Wl serum-free medium) were combined to allow
the formation of DNA^liposome complexes. The
transfection mixtures were incubated at room tem-
perature for 15 min and 0.8 ml of serum free medium
added to the tube containing the complexes. Treated
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cells were resuspended in 10 ml RPMI 1640 medium
plus 10% fetal bovine serum and incubated for 48 h.
G418 (200 Wg/ml) was used for clonal selection of
cells by performing 1:10 dilutions for 10 passages.
3. Results
3.1. PGA2/v12-PGJ2 that inhibit cell proliferation by
apoptosis
To investigate the speci¢c e¡ects of PGA2 and v12-
PGJ2 on cell viability, we measured the proliferation
of Hep3B cells after treatment of PGA2/v12-PGJ2
into cells. As Hep3B cells were treated with increas-
ing amounts of PGs from 0.5 to 20 Wg, cell viability
was shown to decrease as a time- and dose-depend-
ent manner. Cell viability was started to decrease at
24 h post-treatment of PGs and these decreases were
maintained until 96 h post-treatment of PGA2 and
v12-PGJ2 at 20 and 5 Wg/ml, respectively (Fig. 1). The
suppression of Hep3B cell growth by PGs is thought
to be due to largely to apoptosis [22]. Previously, we
demonstrated that PGs are very e¡ective and strong
inducers of apoptosis of several cancer cell lines at
constant concentration [12,13,22,23]. To see whether
PGs have an e¡ect on apoptosis of Hep3B cells, we
analyzed DNA fragmentation characteristic to apop-
tosis (Fig. 2). Total cellular genomic DNA isolated
from PGA2/v12-PGJ2-treated Hep3B cells was ana-
lyzed on native agarose gels. PGA2 can induce sig-
ni¢cant DNA fragmentation at 48 h after treatment
time dependently (Fig. 2A). v12-PGJ2 also showed a
qualitatively similar amount of DNA fragmentation
at 72 h (Fig. 2B).
3.2. Activation of c-myc by PGA2/v12-PGJ2
Next, we examined whether PG-induced apoptosis
in Hep3B cells is related to an upstream regulatory
mechanism involving c-Myc and/or Bcl-2. The levels
of c-myc and bcl-2 mRNAs were detected by a
Northern blot analysis to assess the e¡ects of PGs
on the expression of both positive and negative reg-
ulators of apoptosis. As the incubation times with
PGs were increased, the levels of c-myc mRNA
were increased up to approximately 10-fold greater
than those of control. The accumulation of c-myc
mRNA was sustained until 48 h after treatment of
cells with PGA2/v12-PGJ2 (Fig. 3A). v12-PGJ2 also
displayed the signi¢cant induction of c-myc mRNA,
showing a maximum of approximately 20-fold at 24 h
Fig. 1. E¡ect of PGA2/v12-PGJ2 on cell viability of Hep3B
cells. Cells were incubated with 20 Wg/ml of PGA2 and 5 Wg/ml
of v12-PGJ2 in a 96-well microtiter plate with triplicate for the
indicated times and the viability was assessed by the MTT
method.
Fig. 2. Time course of DNA fragmentation in Hep3B cells by
PGA2/v12-PGJ2. Cells were incubated with PGA2 (20 Wg/ml, A)
and v12-PGJ2 (5 Wg/ml, B) for 6, 12, 24, 48 and 72 h. C, con-
trol; M represents a 100-bp DNA ladder as a size marker.
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Fig. 3. Analysis of PGA2/v12-PGJ2-mediated c-myc induction
by Northern (A,C) and Western blots (B,D). Cells were incu-
bated at di¡erent time periods after treatment with PGA2 (A,B)
and v12-PGJ2 (C,D) at 20 and 5 Wg/ml, respectively. Relative
levels of RNA were quantitated by the densitometric scanning
and normalized with control RNA.
Fig. 4. Induction of hsp70 mRNA in Hep3B cells by PGA2/
v12-PGJ2. Cells were incubated at various time points (1, 3, 6,
12 and 24 h) after treatment with PGA2 (A,B; 20 Wg/ml) and
v12-PGJ2 (C,D; 5 Wg/ml) and examined by Northern (A,C) and
Western blots (B,D). Total cellular RNA was extracted, electro-
phoresed and hybridized with a probe speci¢c for hsp70. Rela-
tive levels of RNA were quantitated by the densitometric scan-
ning and normalized with control RNA.
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post-treatment (Fig. 3C). The induction of endoge-
nous c-Myc protein was measured using a monoclo-
nal antibody speci¢c for c-Myc. The production of
the c-Myc oncoprotein was gradually increased and
consistent with the expression of c-myc mRNA (Fig.
3B,D). The intracellular levels of c-myc were in-
creased approximately 10- to 30-fold greater than
these of control and the elevated levels were main-
tained until the onset of DNA fragmentation speci¢c
for apoptosis. Whereas bcl-2 was not induced in the
model of apoptosis by PGs in Hep3B cells (data not
shown). These results suggest that c-myc may mod-
ulate Hep3B cell death induced by PGA2/v12-PGJ2,
while bcl-2 is not likely to inhibit these cell death.
3.3. PGA2/v12-PGJ2 induces transcription of hsp70
To investigate a possible role for HSP70 in regu-
lating PGs-induced apoptosis of Hep3B cells, ¢rst,
the level of endogenous hsp70 were measured by a
Northern blot analysis after treatment with PGA2/
v12-PGJ2 at various time points. The levels of
hsp70 were rapidly increased in response to PGA2/
v12-PGJ2 (Fig. 4A,C). As shown in Fig. 4A, PGA2
can in£uence the induction of hsp70 mRNA in
Hep3B cells. When Hep3B cells were incubated at
various time points shown in Fig. 4B after treatment
with PGA2, the induction of hsp70 mRNA was ob-
served as a time-dependent manner. In addition, v12-
PGJ2 also showed the induction of hsp70 mRNA
(Fig. 4C). The induction of endogenous HSP70 pro-
tein was gradually increased at 1^6 h (Fig. 4D). This
induction of HSP70, protecting cells against a variety
of stresses by an unknown mechanism, was observed
prior to DNA fragmentation characteristic to apop-
tosis.
3.4. E¡ect of HSP70 overexpression on cell growth
and exposure to PGA2/v12-PGJ2
To examine the e¡ect of enhanced level of HSP70
in PGs-induced apoptosis, mammalian expression
Fig. 5. HSP70 prevents PGA2/v12-PGJ2-mediated apoptosis. Overexpression of HSP70 in Hep3B cells transfected with human hsp70
cDNA as detected by an antibody speci¢c for human HSP70 (A) and Hep3B cells transfected with vector alone (neo) or with vector
expressing human hsp70 cDNA were treated with 20 Wg/ml of PGA2 and 5 Wg/ml of v12-PGJ2 and cell viability was measured by the
MTT methods (B).
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plasmid were constructed in which the complementa-
ry DNA for hsp70 was placed under the control of a
cytomegalovirus (CMV) promoter. Hep3B cells were
transfected with the hsp70 expression plasmid and
were placed under G418 selection. We ¢rst carried
out a Western blot analysis using a monoclonal
HSP70 antibody to assure the production of
HSP70 (Fig. 5A). Transfection with the hsp70 ex-
pression plasmid showed the suppression of Hep3B
cell death induced by PGA2/v12-PGJ2. In contrast,
cell death was observed following transfection with
the backbone expression vector (Fig. 5B)
3.5. PGA2/v12-PGJ2 induced apoptosis is inhibited by
HSP70 overexpression
To further investigate whether overexpression of
HSP70 may have the speci¢c e¡ects on apoptosis,
we used annexin-V-Fluos to detect the levels of
apoptosis in Hep3B cells by £uorescence microscopy
(Fig. 6). The transfected Hep3B cells with the back-
bone expression plasmid induced apoptosis in these
cells, as veri¢ed by staining of a number of apoptotic
cells (Fig. 6D). In contrast, relatively low levels of
apoptosis were observed in cells transfected with the
hsp70 expression plasmid (Fig. 6C). Similar results
were observed when Hep3B cells were treated with
v12-PGJ2 (data not shown). We also examined DNA
fragmentation that is considered to be hallmark of
apoptosis. Genomic DNAs were isolated from trans-
fected cells with either hsp70 or backbone expression
vector and analyzed on a native agarose gel. As
shown in Fig. 7, DNA fragmentation was clearly
induced by PGA2/v12-PGJ2, while HSP70 suppresses
DNA fragmentation induced by PGs in Hep3B cells.
3.6. E¡ects of c-myc antisense oligodeoxynucleotide
on PGA2/v12-PGJ2-induced apoptosis
To determine whether c-myc could regulate the
Fig. 6. Double staining £uorescence microscopic analysis of apoptosis in Hep3B cells. Cells were stained with annexin V and propidi-
um iodide, after which the cells were treated with PGA2 (20 Wg/ml). Cells were transfected as described in Section 2. (A,B) No trans-
fected cells. (C) Transfected cells with hsp70. (D) Transfected cells with pBK-CMV (vector). (B^D) treated with PGA2 (5 Wg/ml) for
48 h.
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expression of HSP70 in PGs-treated Hep3B cells,
cells were transiently transfected with either the sense
or anti-sense oligonucleotide to the c-myc mRNA at
5 Wg/ml for 6 h and then stimulated with PGA2/v12-
PGJ2. The production of endogenous c-Myc was
measured by a Western blot with a monoclonal anti-
body speci¢c for the c-Myc oncoprotein (Fig. 8A).
Sense oligonucleotide has shown no e¡ects on the
induction of endogenous HSP70, while antisense oli-
gonucleotide to the c-myc mRNA showed the de-
layed induction of HSP70 expression (Fig. 8B,C) as
well as the inhibition of DNA fragmentation in
PGA2/v12-PGJ2 treated Hep3B cells (Fig. 8D). This
result demonstrates that the induction of c-myc may
indirectly modulate the expression of HSP70 in
PGA2/v12-PGJ2-mediated apoptosis of Hep3B cells.
Taken together, the suppression of Hep3B cell
Fig. 7. Agarose gel electrophoresis of extracted DNA from
Hep3B cells treated with PGA2/v12-PGJ2 for 72 h. Cells were
treated with either 20 Wg/ml PGA2 or 5 Wg/ml v12-PGJ2. Lane
1, control; lanes 2 and 3, transfected with vector alone; lanes
4 and 5, transfected with human hsp70.
Fig. 8. Antisense c-myc oligonucleotide prevents PGA2/v12-PGJ2-induced Hep3B cell apoptosis and regulated activation of HSP70.
(A) The production of c-Myc in cells transfected with the c-myc antisense oligonucleotide using an antibody speci¢c for human c-
Myc. (B) Expression of HSP70 protein in cells transfected with c-myc antisense oligonucleotide following treatment with PGA2. (C)
Expression of HSP70 protein in cells transfected with c-myc antisense oligonucleotide following treatment with v12-PGJ2. (D) Agarose
gel analyses of DNA fragmentation at various induction times after PGA2 (A; 20 Wg/ml) and v12-PGJ2 (B; 5 Wg/ml) for 0, 6, 12, 24,
48 and 72 h (lanes, 2^7, respectively). Lanes 1 represent a 100-bp DNA ladder as a marker.
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death induced by PGs is likely to be related to the
induction of HSP70 in conjunction with modulation
of c-myc.
4. Discussion
Antiproliferative e¡ects of PGs correlate with the
modulation of expression of several genes, including
the reduction of c-myc [17], the induction of p53, p21
(WAF-1/CIP-1) [13] and HSP70 [24^26]. It was also
reported that the expression of heme oxygenase and
gadd153, DNA damage-inducible gene was induced
during PGA2/v12-PGJ2 induced growth arrest of hu-
man cancer cells [19,20]. Previously, we demon-
strated that the induction of p53 and p21 by v12-
PGJ2 can mediate the regulation of apoptosis in
SK-Hep-1 cells [13]. Several lines of evidence have
shown that the increased expression of either c-myc
or hsp70 was observed in apoptosis induced by cel-
lular stimuli, such as cytokines and hormones, but,
the mechanisms involved in the induction of c-myc
and hsp70 mRNA expression remain to be elucidated
[15,16,23,26].
Evan et al. demonstrated that c-myc can be a po-
tent inducer of apoptosis in immortalized rat-1 ¢bro-
blasts and primary rat embryo ¢broblasts (REFs)
[15]. Chinese hamster ovary cells that overexpressed
c-myc also died by apoptosis [27]. In contrast, other
studies have shown that the reduction of c-myc ex-
pression in HL-60 cells treated with various di¡er-
entiation inducers, such as dimethyl sulfoxide
(DMSO), retinoic acid and 1,25-dihydroxyvitamin
D3, is associated with the inhibition of cell prolifer-
ation and di¡erentiation [17]. The down regulation
of c-myc has been observed during the apoptosis of
Jurkat cells induced by several known T-cell activa-
tors [35]. Therefore, up- and down-regulation of c-
myc may be crucial for cell death and cell survival in
di¡erent situations. An understanding of its involve-
ment will be elucidated how the control of apoptosis
contributes to normal development and disease
states, including cancer.
In this study, we demonstrated that human hepa-
tocarcinoma Hep3B cells, devoid of a functional p53,
lead to their cell death through apoptosis induced by
PGA2 and v12-PGJ2, as veri¢ed by changes in cellu-
lar morphology and DNA fragmentation. Our results
showed that the induction of c-myc mRNA occurs
prior to DNA fragmentation and may mediate the
expression of HSP70. It has been reported that the c-
Myc protein activates hsp70 expression. The se-
quence between 3200 and 3780 bases upstream of
the Drosophila hsp70 promoter was necessary for this
regulation [38]. Similarly, in the human hsp70 gene,
the upstream sequence from 3120 to 31250 bases
plays a major role in transcriptional regulation by
the c-Myc protein [39]. Takahiro et al. reported
that c-Myc protein or protein complex contribute
to the regulation of HSP70 gene expression by bind-
ing directly to the promoter region [28]. Further-
more, we suggest that inhibition of endogenous c-
myc using the antisense oligonucleotide speci¢c to
c-myc leads to the delayed induction of HSP70 and
the inhibition of PGA2/v12-PGJ2-mediated apoptosis
of Hep3B cells. When Hep3B cells were transfected
with c-myc antisense oligomer, the expression of
HSP70 protein was inhibited at early stage (1^6 h),
and resulted in induction of HSP70, starting 12 h
after PGA2/v12-PGJ2 treatment. This result demon-
strates that c-myc may indirectly modulate the ex-
pression of PGA2/v12-PGJ2-induced hsp70 in
Hep3B cells. But, the expression of hsp70 at 12 h
may be either induced by speci¢c heat shock tran-
scription factor, growth factor or by intracellular
Ca2 and cAMP.
It is well known that HSP70 is induced by cell
cycle-dependent and various physiological stimula-
tions. In particular, many investigators reported
that HSP70 could play an essential role of resistance
to cytotoxicity in cellular processes and also inhibits
apoptosis triggered by several stimuli. Samali et al.
have demonstrated that cells with an elevated expres-
sion of heat shock proteins, induced by either mild
hyperthermia or by transfection of hsp70, are resist-
ant to apoptosis induced by a variety of toxic agent
[40]. The induction of HSP70 in tumor cells renders
them partially resistance to TNF-K and -L mediated
cytotoxicity [30]. In 1993, Mailhos et al. demon-
strated that transfection of neuronal cells with
HSP70 and HSP90 protected them against thermal
stress [2]. In addition, HSP70 plays a central role not
only in cell protection against UV-light, but also in
the regulation of pro-in£ammatory cytokine release
induced by UV-exposure [29]. HSP70 inhibited
mononuclear cell production of pro-in£ammatory
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genes, such as TNF-K [31], IL-1L [32] and inducible
nitric oxide synthase (iNOS) [33,34]. The main func-
tion of these proteins in time of stress is to a¡ord
protection to cells from various stimuli. When the
stress element is removed, these cells continue to
function normally and the hsp level drops back to
the normal level. However, if the level of stress is
increased, the presence of heat shock proteins may
be unable to protect the cells, hsp synthesis stops,
and at this stage the program for apoptosis is acti-
vated [41].
In this report, we demonstrates that overexpres-
sion of hsp70 can protect Hep3B cells from apoptosis
by PGA2/v12-PGJ2. Con¢rming the results obtained
by £uorescence microscopy, relatively low levels of
apoptosis were observed in cells transfected with the
hsp70 expression plasmid. Also, the expression of
HSP70 showed the suppression of DNA fragmenta-
tion induced by PGA2/v12-PGJ2. Our results showed
that the transfected hsp70 did not a¡ect the growth
of Hep 3B cells. But, in Fig. 5, the growth of cells
transfected with hsp70 was inhibited at 72 h. This is
not because the direct e¡ect of hsp70, but because of
the cell con£uence. It is possible that in cells re-
sponding to PGs, the HSP70 may function as a crit-
ical endogenous activation of inhibitable pathway of
PGA2/v12-PGJ2-mediated apoptosis and may specif-
ically play the important role in the signal transduc-
tion pathway of PGs action and modulation of gene
expression
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